Arising Health · Podcast
The Arising Signal.
Sarah and Michael discuss the day’s reporting on longevity, medicine, and the business of health.
Subscribe via RSS ↗
Latest episode
Hormone therapy and heart risk
Sarah and Michael open with a study of hormone therapy in midlife. They also discuss mitochondrial replacement in fertility clinics, a liver fibrosis trial, and investment in senior housing.
Earlier episodes
What do slow waves during REM sleep tell us?
Sleep researchers are finding unexpected patterns in REM sleep as people age. Also in this edition: a heart valve designed for growing children, biological age estimates, and changes in Medicare Advantage.
Remission in type 2 diabetes
The hosts discuss the RESET trial in younger adults with type 2 diabetes, a small trial in liver fibrosis, and changes to estrogen patch labeling.
A pill for sleep apnea?
An investigational pill for sleep apnea leads this edition. Sarah and Michael also cover a gene-editing trial, blood pressure medication, and what happens after people stop taking tirzepatide.
An early glaucoma trial
What can researchers learn from the first three patients in a reprogramming trial? The hosts also discuss a melanoma vaccine, bone density during weight loss, and an Alzheimer’s trial.
AFTER LISTENING
Follow the story on the page.
Read the newsletter archive, explore a subject in depth, or follow the original research.